E-Motion Medical is the developer of the E-Motion System, which treats gastrointestinal (GI) dysmotility. The companys proprietary technology is designed to reinstate digestive motor function and improve nutritional tolerance and safety for patients otherwise susceptible to catabolism, infections, and other complications. More than 200 patients were enrolled in several E-Motion clinical trials in over a dozen hospitals around the world. The trials demonstrated the safety of the technology and the effects of the stimulation on gastric emptying, reflux and aspiration, and recuperation time for ICU patients, while at the same time minimizing the medical staffs workload. E-Motions Medicals first line of products has received CE mark approval for sale in the European Union.